CD274 and neoplasm: Furthermore, they also demonstrated that CD38 knock out tumors exhibit delayed growth when compared to CD38+ wild-type tumors in wild-type mice and that in tumor-bearing mice, combination of anti-CD38 antibody and anti-PDL-1 acts synergistically to suppress tumor growth and dissemination.